BALTHASER KEVIN (Chief Financial Officer) exercised options at ACLARIS THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/5/2026ACC: 0001957554-26-000007
Officer· Chief Financial Officer
Since Mar 2026
-6.45K
Net shares
Net seller
$22.4K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
22.02K acquired · 28.47K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+22.02K
Price / share
—
Trade value
—
% of position
12.9%
2/3/2026
170.18K→192.20K
Common Stock
Direct
Shares
−6.45K
Price / share
$3.47
Trade value
$22.38K
% of position
3.4%
2/3/2026
192.20K→185.75K
Total
Net shares
+15.58K
Net value
-$22.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | M · Option Exercise | +22.02K | — | — | 12.9% | 170.18K | 192.20K |
| Common Stock Direct | 2/3/2026 | F · Tax Withholding | −6.45K | $3.47 | $22.38K | 3.4% | 192.20K | 185.75K |
| Total | +15.58K | -$22.38K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
22.02K shares
Shares
−22.02K
Strike price
Held after
66.08K
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock22.02K shares | 2/3/2026 | M · Option Exercise | −22.02K | — | 66.08K |